推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-34243363

chinasupport@letpub.com

登录 注册 新注册优惠

Discovery Medicine

2024年6月最新影响因子数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

按期刊名首写字母查看 DISCOV MED最新评论:请问接受了吗 (2024-09-11)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中国科学院分区:   是否OA期刊:   结果排序:
 
同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


Discovery Medicine期刊基本信息Hello,您是该期刊的第32825位访客


基本信息 登录收藏
期刊名字Discovery MedicineDiscovery Medicine

DISCOV MED
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
5.2
50人评分
我要评分

声誉
6.4

影响力
3.8

速度
7.0

期刊ISSN1539-6509
微信扫码收藏此期刊
E-ISSN1944-7930
2023-2024最新影响因子
(数据来源于搜索引擎)
2 点击查看影响因子趋势图
实时影响因子 截止2024年10月29日:1.632
2023-2024自引率5.00%点击查看自引率趋势图
五年影响因子2.8
JCI期刊引文指标 0.43
h-index 25
CiteScore
2024年最新版
CiteScoreSJRSNIPCiteScore排名
5.400.8070.749
学科分区排名百分位
大类:Medicine
小类:General Medicine
Q129 / 529

期刊简介
Discovery Medicine is an evidence-based, peer-reviewed, open-access, and scholarly biomedical journal indexed in MEDLINE/PubMed by the U.S. National Library of Medicine. It is a premier source of important information, knowledge, and insights in translational and clinical research. Discovery Medicine provides a global professional publishing platform and facilitates the exchange of critical information between scientists, physicians, patients, and the healthcare industry — aiding research, patient care delivery, and humanity. Discovery Medicine pioneers a new movement and is passionate about compelling the free flow of cutting-edge, professional biomedical discovery research information from research laboratories to a diverse, large audience (not just limited to a handful of researchers in a particular field). The consequence of this rapid and wider availability of information is a more productive usage of biomedical research findings.


Discovery Medicine publishes novel, provocative ideas and research findings that challenge conventional notions about disease mechanisms, diagnosis, treatment, or any of the life sciences subjects. It publishes cutting-edge, reliable, and authoritative information in all branches of life sciences but primarily in the following areas: Novel therapies and diagnostics (approved or experimental); innovative ideas, research technologies, and translational research that will give rise to the next generation of new drugs and therapies; breakthrough understanding of mechanism of disease, biology, and physiology; and commercialization of biomedical discoveries pertaining to the development of new drugs, therapies, medical devices, and research technology.

Discovery Medicine publishes evidence-based reviews and original research articles. Please see “For Authors” for details.
期刊官方网站https://www.discovmed.com/EN/home
期刊投稿网址https://www.discovmed.com/Journalx_dm/authorLogOn.action
作者指南网址https://www.discovmed.com/EN/column/column11.shtml
期刊语言要求经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Discovery Medicine的语言要求,还能让Discovery Medicine编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Discovery Medicine编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢
提交文稿
是否OA开放访问Yes
通讯方式10 GERARD AVE, STE 201, TIMONIUM, USA, MD, 21093
出版商Timonium, MD : Discovery Medicine
涉及的研究方向MEDICINE, RESEARCH & EXPERIMENTAL-
出版国家或地区UNITED STATES
出版语言English
出版周期Monthly
出版年份2001
年文章数 115点击查看年文章数趋势图
Gold OA文章占比0.57%
研究类文章占比:
文章 ÷(文章 + 综述)
86.09%
WOS期刊SCI分区
2023-2024年最新版
WOS分区等级:3区

按JIF指标学科分区收录子集JIF分区JIF排名JIF百分位
学科:MEDICINE, RESEARCH & EXPERIMENTALSCIEQ3122/189
按JCI指标学科分区收录子集JCI分区JCI排名JCI百分位
学科:MEDICINE, RESEARCH & EXPERIMENTALSCIEQ3136/189
中国科学院《国际期刊预警
名单(试行)》名单
2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
中国科学院SCI期刊分区
2023年12月最新升级版
点击查看中国科学院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 3区4区2区
MEDICINE, RESEARCH & EXPERIMENTAL
医学:研究与实验
4区1区4区
中国科学院SCI期刊分区
2022年12月升级版
大类学科小类学科Top期刊综述期刊
医学 2区4区2区
MEDICINE, RESEARCH & EXPERIMENTAL
医学:研究与实验
3区4区4区
中国科学院SCI期刊分区
2021年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 1区4区3区
MEDICINE, RESEARCH & EXPERIMENTAL
医学:研究与实验
1区4区4区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1539-6509%5BISSN%5D
平均审稿速度网友分享经验:
较慢,6-12周
平均录用比例网友分享经验:
较易
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在Discovery Medicine顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
编辑信息 Editor-in-Chief
Benjamin Yang, MD, PhD
Department of Neurology, Johns Hopkins University, Baltimore, MD, USA
期刊常用信息链接
同领域相关期刊 Discovery Medicine期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 Discovery Medicine中国科学院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
Discovery Medicine上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中国科学院分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发文
  • 中国科学院分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144873.20
    NATURE REVIEWS DRUG DISCOVERY289137.40
    LANCET700148.10
    NEW ENGLAND JOURNAL OF MEDICINE933145.40
    BMJ-British Medical Journal019.90
    BMJ-British Medical Journal019.90
    Nature Reviews Clinical Oncology12799.40
    Nature Reviews Disease Primers4876.70
    NATURE REVIEWS CANCER396111.90
    NATURE REVIEWS IMMUNOLOGY35193.40
    中国科学院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE677700
    BIOMATERIALS567285
    BIOMEDICINE & PHARMACOTHERAPY552018
    Frontiers in Pharmacology515786
    Journal of Materials Chemistry B506974
    Frontiers in Immunology492571
    COMPUTERS IN BIOLOGY AND MEDICINE474436
    JOURNAL OF ETHNOPHARMACOLOGY466711
    COLLOIDS AND SURFACES B-BIOINTERFACES438831
    Frontiers in Oncology436521
  •  

    Discovery Medicine Discovery Medicine
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.Prediction and prognosis of biologically aggressive breast cancers by the combination of DWI/DCE-MRI and immunohistochemical tumor markers.

    Author: Allarakha A1, Gao Y1, Jiang H1, Wang PJ1.
    Journal: Discov Med. 2019 Jan;27(146):7-15.
        PubMed  
    2.Synovial fluid alpha-melanocyte-stimulating hormone may act as a protective biomarker for primary knee osteoarthritis.

    Author: Guan J1, Li Y1, Ding LB1, Liu GY1, Zheng XF2, Xue W3, Wang HJ2.
    Journal: Discov Med. 2019 Jan;27(146):17-26.
        PubMed  
    3.Targeting cyclin-dependent kinases in gastrointestinal cancer therapy.

    Author: Zhang J#1,2,3,4, Su G#2, Lin Y1,2,3,4, Meng W1,2,3,4, Lai JKL5, Qiao L5, Li X6,3,4, Xie X2.
    Journal: Discov Med. 2019 Jan;27(146):27-36.
        PubMed  
    4.Advances in the techniques and methodologies of cancer gene therapy.

    Author: Sun W1, Shi Q2, Zhang H2, Yang K2, Ke Y2, Wang Y3,4, Qiao L5.
    Journal: Discov Med. 2019 Jan;27(146):45-55.
        PubMed  
    5.Epigallocatechin-3-gallate suppresses pain-related and proinflammatory mediators in the subacromial bursa in rotator cuff tendinopathy.

    Author: Feng H1,2,3, He Z2,3, Twomey K2, Ilaltdinov AW2,3, Leong D2,3, Wang Y4, Li J1, Gonzalez D2, Sun HB2,3.
    Journal: Discov Med. 2019 Feb;27(147):63-77.
        PubMed  
    6.Genetic association and interaction of PD1 and TIM3 polymorphisms in susceptibility of chronic hepatitis B virus infection and hepatocarcinogenesis.

    Author: Li F1, Fan X1, Wang X1, Deng H1, Zhang X1, Zhang K1, Li N1, Han Q1, Lv Y2, Liu Z1,3.
    Journal: Discov Med. 2019 Feb;27(147):79-92.
        PubMed  
    7.Modulation of cancer immunotherapy efficacy by gut microbiota.

    Author: Huo S1, Liu L2, Liu J2, Li Q3, Wang J2.
    Journal: Discov Med. 2019 Feb;27(147):93-100.
        PubMed  
    8.Hypertriglyceridemia-induced acute pancreatitis: progress on disease mechanisms and treatment modalities.

    Author: Guo YY#1, Li HX#1, Zhang Y2, He WH2.
    Journal: Discov Med. 2019 Feb;27(147):101-109.
        PubMed  
    9.Stationary phase persister/biofilm microcolony of Borrelia burgdorferi causes more severe disease in a mouse model of Lyme arthritis: implications for understanding persistence, Post-treatment Lyme Disease Syndrome (PTLDS), and treatment failure.

    Author: Feng J1,2, Li T1,2, Yee R1, Yuan Y1, Bai C1, Cai M1, Shi W1, Embers M3, Brayton C4, Saeki H4, Gabrielson K4, Zhang Y1,5.
    Journal: Discov Med. 2019 Mar;27(148):125-138.
        PubMed  
    10.Predictive ability of DWI/ADC and DCE-MRI kinetic parameters in differentiating benign from malignant breast lesions and in building a prediction model.

    Author: Allarakha A1, Gao Y1, Jiang H1, Wang GL1, Wang PJ1.
    Journal: Discov Med. 2019 Mar;27(148):139-152.
        PubMed  
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144873.20
    NATURE REVIEWS DRUG DISCOVERY289137.40
    LANCET700148.10
    NEW ENGLAND JOURNAL OF MEDICINE933145.40
    BMJ-British Medical Journal019.90
    BMJ-British Medical Journal019.90
    Nature Reviews Clinical Oncology12799.40
    Nature Reviews Disease Primers4876.70
    NATURE REVIEWS CANCER396111.90
    NATURE REVIEWS IMMUNOLOGY35193.40
    同分区等级的其他期刊名称 h-index CiteScore
    Energy Material Advances013.80
    Journal of High Energy Astrophysics119.70
    VIEW012.60
    HARVARD BUSINESS REVIEW01.40
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE1086.90
    ACM Transactions on Intelligent Systems and Technology469.30
    Journal of the American Nutrition Association02.50
    TRANSACTIONS OF TIANJIN UNIVERSITY012.50
    Machine Intelligence Research06.70
    Molecular Biomedicine06.30
以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

同领域作者分享投稿经验:共56


    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2024 中国: LetPub上海    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)

    增值电信业务经营许可证:沪B2-20211595    网络文化经营许可证:沪网文[2023]2004-152号

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室